1-(1-ethoxyethyl)-1H-pyrazole-5-carbaldehyde, 500mg

Tetrahydro-2H-pyran-4-yl methanesulfonate, 97.0%, 1g

1-(Hexyloxy)-4-nitrobenzene, 95+%, 25g

(2E)-3-(3-bromophenyl)-1-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 10g

(5,6-Dimethylpyridin-2-yl)methanamine dihydrochloride, 95%, 1g

3-(2-Chloroethyl)quinazoline-2,4(1H,3H)-dione, 95.0%, 1g

3-Fluorobenzylamine>98.0%(GC)(T)25g

2-[(2-oxo-2-phenylethyl)thio]nicotinic acid, 95.0%, 1g

ETHYL (Z)-3-(4-CHLOROPHENYL)-2-CYANOACRYLATE, 97.0%, 5g

3-Chloro-4-methoxy-5-(trifluoromethyl)benzoic acid, 95%, 1g

3'-Trifluoromethylbiphenyl-2-carbaldehyde, 95.0%, 1g

Dipyrazino[2,3-f:2',3'-h]quinoxaline-2,3,6,7,10,11-hexacarbonitrile, 95.0%, 100mg

4-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-((5-nitrothiazol-2-yl)thio)-1H-1,2,4-triazol-5(4H)-one, 95.0%, 250mg